Literature DB >> 22524826

Methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers in ovarian cancer risk.

Song Gao1, Ning Liu, Yang Ma, Liu Ying.   

Abstract

UNLABELLED: Early diagnosis and better prognosis of ovarian cancer is still a challenge. Besides environmental risk factors, genetic factors have established a role in pathogenesis of ovarian cancer.
METHODS: A case-control and a prospective study design conducted in 224 ovarian cancer patients and 432 controls in Chinese population. MTHFR C677T genotyping was done by PCR-RFLP.
RESULTS: Patients with ovarian cancer is associated with a higher less number of delivery and less frequent oral contraceptive use. When potential confounding factors adjusted logistic regression analysis between cases and controls were performed, significant association was obtained for 677T/T genotype and ovarian cancer (OR=3.13, 95% CI=1.59-5.72). Cox regression survival analysis showed individuals carrying T/T genotype had significantly increased HR for death in ovarian cancer patients (HR=2.86, 95% CI=1.27-7.93). In conclusion, we observed that the MTHFR C677T polymorphism is associated with the susceptibility and survival of ovarian cancer in Chinese population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524826     DOI: 10.7314/apjcp.2012.13.2.569

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  5,10-Methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTRR), and methionine synthase reductase (MTR) gene polymorphisms and adult meningioma risk.

Authors:  Jun Zhang; Yan-Wen Zhou; Hua-Ping Shi; Yan-Zhong Wang; Gui-Ling Li; Hai-Tao Yu; Xin-You Xie
Journal:  J Neurooncol       Date:  2013-11       Impact factor: 4.130

2.  The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.

Authors:  Chengbin Ma; Yan Liu; Wenying Zhang; Ping Liu
Journal:  Mol Biol Rep       Date:  2013-01-18       Impact factor: 2.316

3.  Polymorphism of TS 3'-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.

Authors:  J Gao; Q He; D Hua; Y Mao; Y Li; L Shen
Journal:  Clin Transl Oncol       Date:  2012-12-21       Impact factor: 3.405

4.  MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy.

Authors:  Jia Chen; Qi Wang; Fu-Qiang Yin; Wei Zhang; Lin-Hai Yan; Li Li
Journal:  Am J Transl Res       Date:  2015-09-15       Impact factor: 4.060

5.  MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls.

Authors:  Lilin He; Yongxiang Shen
Journal:  Onco Targets Ther       Date:  2017-01-06       Impact factor: 4.147

6.  Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.

Authors:  Ying Xiong; Ce Bian; Xiaojuan Lin; Xiaoli Wang; Kehui Xu; Xia Zhao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

7.  Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis.

Authors:  Mojgan Karimi-Zarchi; Mansour Moghimi; Hajar Abbasi; Amaneh Hadadan; Erfaneh Salimi; Majid Morovati-Sharifabad; Mohammad Javad Akbarian-Bafghi; Masoud Zare-Shehneh; Alireza Mosavi-Jarrahi; Hossein Neamatzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

8.  Polymorphisms in methylenetetrahydrofolate reductase and cystathionine beta-synthase in oral cancer - a case-control study in southeastern Brazilians.

Authors:  Andressa Barbosa; Marcelo Dos Santos; José Roberto Vasconcelos de Podestá; Sônia Alves Gouvêa; Sandra Ventorin Von Zeidler; Iúri Drumond Louro; Melissa de Freitas Cordeiro-Silva
Journal:  Braz J Otorhinolaryngol       Date:  2015-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.